Effect of alogliptin on endothelial dysfunction induced by postprandial hypelipidemia

Effect of alogliptin on endothelial dysfunction induced by postprandial hypelipidemia - Effect of alogliptin on endothelial dysfunction induced by postprandial hypelipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008296

Enrollment

Registered

2012-06-29

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

oral adiministration of alogliptin Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with written informed consent

Exclusion criteria

Exclusion criteria: Subjects receiving hypoglycemic agetnts and/or lipid lowering agents

Design outcomes

Primary

Measure	Time frame
Change in lipid profiles and endothelial function after meal loading test	—

Countries

Japan

Contacts

Public ContactToru Miyoshi

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical S Department of Cardiovascular Medicin

miyoshit@cc.okayama-u.ac.jp086-223-7151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026